Please assess the completion status of the following clinical trial:

Trial Title: Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Children 2 - 12 years old of both sexes, with a diagnosis of Chagas' disease and eligible for treatment with benznidazole, as per current treatment protocols.~* Chagas disease diagnostic criteria: At least 2 positive serological tests for Trypanosoma cruzi infection (ELISA, hemoagglutination, particle agglutination tests).~* Informed consent signed by the parents, and consent or assent of the patients (according to age and consenting capacity).~Exclusion Criteria:~* Patients with a history of hypersensitivity to benznidazole or any of the drug excipients~* Immunocompromised patients~* Altered hepatic function (increase in AST/ALT x3 or bilirubin x3) or altered renal function (increase in creatinine x3)~* Pregnancy

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Benznidazole (Type: EXPERIMENTAL): Treatment of pediatric Chagas disease with benznidazole

Based on this trial design, predict the completion outcome and termination type (if applicable).